Stay updated on RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision indicator changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-03T22:56:33.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A sitewide NIH notice about changing terminology appears, and the displayed site revision advances from v3.7.1 to v3.7.2.
    Difference
    0.6%
    Check dated 2026-10-20T22:21:44.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision updated from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-06T22:09:09.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added. The older v3.6.6 entry was removed from the study record's revision history.
    Difference
    0.1%
    Check dated 2026-09-15T23:27:41.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A new patch-level revision entry, Revision: v3.6.6, was added to the study record history. The previous patch entry, Revision: v3.6.5, was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-09-01T19:35:36.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    A new revision tag v3.6.5 is added to the record history and the previous tag v3.6.4 is removed, reflecting an updated build of the page history.
    Difference
    0.1%
    Check dated 2026-08-11T14:42:22.000Z thumbnail image

Stay in the know with updates to RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.